Angela Hwang - 12 Nov 2021 Form 4 Insider Report for PFIZER INC (PFE)

Signature
Susan E. Grant, by power of atty., for Angela Hwang
Issuer symbol
PFE
Transactions as of
12 Nov 2021
Net transactions value
-$397,988
Form type
4
Filing time
15 Nov 2021, 16:32:19 UTC
Previous filing
17 May 2021
Next filing
25 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Sale $39,688 -800 -3.1% $49.61 25,371 12 Nov 2021 Direct
transaction PFE Common Stock Sale $169,303 -3,412 -13% $49.62 21,959 12 Nov 2021 Direct
transaction PFE Common Stock Sale $527,935 -10,646 -48% $49.59 11,313 12 Nov 2021 Direct
transaction PFE Common Stock Sale $561,075 -11,312 -100% $49.60 1 12 Nov 2021 Direct
holding PFE Common Stock 27,634 12 Nov 2021 By Rule 16b-3 Plan
holding PFE Common Stock 8,532 12 Nov 2021 By Spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $900,014 +18,098 +117% $49.73 33,576 12 Nov 2021 Common Stock 18,098 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by spouse.
F2 Each unit represents one phantom share of common stock.
F3 This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
F4 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.